These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 7668868

  • 1. [Blood levels of 5-FU and uracil on additional use of uracil in UFT therapy in gastrectomized patients].
    Suda Y, Uchida K.
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1343-7. PubMed ID: 7668868
    [Abstract] [Full Text] [Related]

  • 2. [Blood concentrations of futraful, uracil and 5-fluorouracil (5-FU) after UFT administration in the various reconstructions after gastrectomy. Saitama UFT Research Group].
    Suda Y, Uchida K, Okamura H, Oshima Y, Shimizu M, Miyakawa T, Okubo S, Shiina E, Hosoda Y, Tokura Y.
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2181-7. PubMed ID: 1444484
    [Abstract] [Full Text] [Related]

  • 3. [The effect of gastrectomy on serum 5-FU concentrations of patients administered UFT per os].
    Yamamoto Y, Amano T, Fujimoto Y, Imada T, Tamura S, Noguchi Y, Matsumoto A.
    Gan No Rinsho; 1987 Apr; 33(4):377-81. PubMed ID: 3106673
    [Abstract] [Full Text] [Related]

  • 4. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH, Pazdur R, Covington W, Brown N, Huo YY, Lassere Y, Kuritani J.
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
    Tanimura T, Kaneshige E, Fujiwara K, Kobashi Y, Inoue K, Kono I, Sekiba K.
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):349-55. PubMed ID: 3080967
    [Abstract] [Full Text] [Related]

  • 10. [Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
    Tomita T, Tajima T, Ishibashi M, Tagaya N, Aoki H, Itoh S, Kadowaki A, Kogure H, Tajima Y.
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3755-62. PubMed ID: 2512859
    [Abstract] [Full Text] [Related]

  • 11. [Tissue UFT distribution and histological changes following UFT administration in metastatic liver cancer cases].
    Yoshikawa K, Iwasaki T, Amemiya A, Emoto T, Fujii M, Han N, Itou A, Tsujimura T.
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1333-7. PubMed ID: 2114828
    [Abstract] [Full Text] [Related]

  • 12. 5-Ethynyluracil (776C85): effects on the antitumor activity and pharmacokinetics of tegafur, a prodrug of 5-fluorouracil.
    Cao S, Baccanari DP, Joyner SS, Davis ST, Rustum YM, Spector T.
    Cancer Res; 1995 Dec 15; 55(24):6227-30. PubMed ID: 8521418
    [Abstract] [Full Text] [Related]

  • 13. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
    Takahashi N, Nitta A, Saitou T, Mori Y, Kunii Y, Kikuchi K.
    Gan To Kagaku Ryoho; 1988 Aug 15; 15(8):2319-23. PubMed ID: 3136701
    [Abstract] [Full Text] [Related]

  • 14. [Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT].
    Kusama M, Utsunomiya Y, Ono T, Nagura H, Enomoto S.
    Gan To Kagaku Ryoho; 1983 Aug 15; 10(8):1796-802. PubMed ID: 6411004
    [Abstract] [Full Text] [Related]

  • 15. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
    Hoff PM, Pazdur R, Benner SE, Canetta R.
    Anticancer Drugs; 1998 Jul 15; 9(6):479-90. PubMed ID: 9877235
    [Abstract] [Full Text] [Related]

  • 16. [Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT].
    Inaba S, Kondo Y, Tsuchiya K, Kawai K, Ogino A, Umeda T, Ueda Y.
    Gan To Kagaku Ryoho; 1992 Nov 15; 19(13):2175-80. PubMed ID: 1444483
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [5-FU concentration in the tissues (tumor and lymph node) of breast cancer patients given preoperative administration of UFT and FT].
    Koida T, Kimura M.
    Gan To Kagaku Ryoho; 1985 May 15; 12(5):1147-51. PubMed ID: 3922313
    [Abstract] [Full Text] [Related]

  • 19. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
    Takeshita M, Ishikawa H, Seki M, Ikeya T, Miyamoto Y, Izuo M, Tozuka S, Usui R, Kaneko H.
    Gan No Rinsho; 1985 Oct 15; 31(13):1697-703. PubMed ID: 3935831
    [Abstract] [Full Text] [Related]

  • 20. [Comparative pharmacokinetic study between UFT and FT-207 suppo and phase II studies in gynecological malignancies].
    Hatae M, Terahara M, Hokanishi H.
    Gan To Kagaku Ryoho; 1984 Nov 15; 11(11):2386-92. PubMed ID: 6437345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.